Mitochondrial Neurogastrointestinal Encephalomyopathy

Gastroenterology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Entrada Therapeutics
1 program
Non-interventionalN/A1 trial
Active Trials
NCT04245917Suspended60Est. Feb 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Entrada TherapeuticsNon-interventional

Clinical Trials (1)

Total enrollment: 60 patients across 1 trials

Natural History Study of MNGIE

Start: Aug 2020Est. completion: Feb 202660 patients
N/ASuspended

Related Jobs in Gastroenterology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space